The clinically approved antiviral drug sofosbuvir inhibits Zika virus replicationCarolina Q. Sacramento, Thiago Moreno L. Souza, Lucas Villas Bôas Hoelz et al.|Scientific Reports|2017Cited by 243
The clinically approved antiviral drug sofosbuvir impairs brazilian zika virus replicationCaroline Q. Sacramento, Thiago Moreno L. Souza, Gabrielle R. de Melo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2016Cited by 25